As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
On the Lookout: The Software Supply Chain as a Healthcare Cyberattack Vector
Hackensack Meridian Health & Wellness Center at Clifton Opens
Suffolk Breaks Ground on Expansion of White Plains Hospital
EVS Leadership Culture Critical in Preventing Hospital-Acquired Sepsis
Man Dies by Suicide in Emergency Department Waiting Room at Kansas Hospital